CRNX logo

Crinetics Pharmaceuticals, Inc. (CRNX)

Profile

Full Name

Crinetics Pharmaceuticals, Inc.

Ticker

NASDAQ: CRNX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 18, 2018

Indexes

Not included

Website

https://www.crinetics.com

Employees

437

Key Details

Price

$36.50(+3.87%)

Market cap

$3.44B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.04M(-74.11% YoY)

Annual EPS

-$3.69(0.00% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $36.50
    CRNX price is $36.50

    30-Day Relative Volume

    1.30
    CRNX 30-day relative volume is 1.30

    Price Performance

    Price Most recent change

    +3.87%
    CRNX price was up +3.87% on Sep 9, 2025

    Price YTD change

    -28.61%
    CRNX price is down -28.61% since January 1st

    Price 1-year change

    -30.13%
    CRNX price is down -30.13% year-on-year

    Price 3-year change

    +73.56%
    CRNX price is up +73.56% over the past 3 years

    Price Range

    Price All-time high

    $62.53
    CRNX price is currently -41.63% below its historical high of $62.53

    Price 3-year low

    $15.23
    CRNX price is currently +139.66% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.44B
    CRNX market capitalization is $3.44 billion

    Market cap 3-year change

    +204.08%
    CRNX market capitalization is up +204.08% over the past 3 years

    Market cap All-time high

    $5.63B
    CRNX market capitalization is currently -38.93% below its historical high of $5.63 billion

    Market cap sector rank

    85.89%
    CRNX market capitalization is higher than 85.89% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +17.67%
    CRNX shares outstanding is up +17.67% year-on-year

    Shares Outstanding 3-Year Change

    +75.2%
    CRNX shares outstanding is up +75.2% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.17
    CRNX beta is 1.17

    200-day SMA

    $36.31
    CRNX price is currently +0.51% above its 200-day simple moving average

    50-day SMA

    $30.58
    CRNX price is currently +19.34% above its 50-day simple moving average

    RSI

    71.12
    CRNX 14-day relative strength index is 71.12

    Volume

    1.30
    CRNX 30-day relative volume is 1.30

    ATR

    $1.52
    CRNX average true range is $1.52

    10-day Historical Volatility

    46.97%
    CRNX 10-day historical volatility is 46.97%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.04M
    CRNX annual revenue is $1.04 million

    Revenue Analysts estimate

    $5.65M
    CRNX annual revenue is currently -81.61% lower than the consensus analysts' forecast

    Revenue 1-year change

    -74.11%
    CRNX annual revenue is down -74.11% year-on-year

    Revenue Sector rank

    37.44%
    CRNX annual revenue is higher than 37.44% of companies in Healthcare sector

    EPS

    EPS

    -$3.69
    CRNX annual earnings per share is -$3.69

    EPS Analysts estimate

    -$4.67
    CRNX annual earnings per share is currently -20.91% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    CRNX annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    24.71%
    CRNX annual earnings per share is higher than 24.71% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.75M
    CRNX annual gross profit is -$1.75 million

    Gross margin

    -168.05%
    CRNX annual gross profit margin is -168.05%

    Operating profit

    -$338.85M
    CRNX annual operating income is -$338.85 million

    Operating margin

    -32.61K%
    CRNX annual operating profit margin is -32.61 thousand%

    Net income

    -$298.41M
    CRNX annual net profit is -$298.41 million

    Net margin

    -28.72K%
    CRNX annual net profit margin is -28.72 thousand%

    Expenses

    Total expenses

    $339.89M
    CRNX annual total expenses is $339.89 million

    Operating expenses

    $339.89M
    CRNX annual total operating expenses is $339.89 million

    Cost of goods sold

    $2.79M
    CRNX annual cost of goods sold is $2.79 million

    Selling, general & administrative expenses

    $99.74M
    CRNX annual SGA is $99.74 million

    Depreciation and amortization

    $2.79M
    CRNX annual depreciation & amortization is $2.79 million

    Interest expense

    $0.00
    CRNX annual interest expense is $0.00

    Income tax

    $0.00
    CRNX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$338.85M
    CRNX annual earnings before interest & taxes is -$338.85 million

    EBITDA

    -$336.07M
    CRNX annual EBITDA is -$336.07 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.73B
    CRNX annual total assets is $1.73 billion

    Non current assets

    $59.20M
    CRNX annual long term assets is $59.20 million

    Current assets

    $1.38B
    CRNX annual total current assets is $1.38 billion

    Cash and cash equivalents

    $264.55M
    CRNX annual cash & cash equivalents is $264.55 million

    Accounts receivable

    -
    CRNX annual accounts receivable value is unknown

    Inventory

    $0.00
    CRNX annual inventory is $0.00

    Liabilities

    Total liabilities

    $401.32M
    CRNX annual total liabilities is $401.32 million

    Long term liabilities

    $50.10M
    CRNX annual total long term liabilities is $50.10 million

    Current liabilities

    $59.68M
    CRNX annual total current liabilities is $59.68 million

    Accounts payable

    $5.85M
    CRNX annual accounts payable is $5.85 million

    Debt

    Total debt

    $51.72M
    CRNX annual total debt is $51.72 million

    Total debt 1-year change

    -0.01%
    CRNX annual total debt is down -0.01% year-on-year

    Long term debt

    $44.57M
    CRNX annual long term debt is $44.57 million

    Short term debt

    $7.15M
    CRNX annual short term debt is $7.15 million

    Equity & Capital

    Shareholders equity

    $1.32B
    CRNX annual stockholders equity is $1.32 billion

    Book value

    $1.32B
    CRNX annual book value is $1.32 billion

    Retained earnings

    -$952.11M
    CRNX annual retained earnings is -$952.11 million

    Working capital

    $1.32B
    CRNX annual working capital is $1.32 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$225.97M
    CRNX annual cash flow from operations is -$225.97 million

    Cash from operations 1-year change

    -35.88%
    CRNX annual cash flow from operations is down -35.88% year-on-year

    Cash from investing

    -$574.82M
    CRNX annual cash flow from investing activities is -$574.82 million

    Cash from investing 1-year change

    -186.82%
    CRNX annual cash flow from investing activities is down -186.82% year-on-year

    Cash from financing

    $1.01B
    CRNX annual cash flow from financing activities is $1.01 billion

    Cash from financing 1-year change

    +159.79%
    CRNX annual cash flow from financing activities is up +159.79% year-on-year

    CAPEX

    CAPEX

    $3.84M
    CRNX annual capital expenditures is $3.84 million

    CAPEX 1-year change

    -18%
    CRNX annual capital expenditures is down -18% year-on-year

    Free Cash Flow

    Free cash flow

    -$229.81M
    CRNX annual free cash flow is -$229.81 million

    Free cash flow 1-year change

    -34.4%
    CRNX annual free cash flow is down -34.4% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -168.05%
    CRNX annual gross profit margin is -168.05%

    Operating margin

    -32.61K%
    CRNX annual operating profit margin is -32.61 thousand%

    Net margin

    -28.72K%
    CRNX annual net profit margin is -28.72 thousand%

    ROA & ROE

    ROA

    -25.27%
    CRNX annual return on assets is -25.27%

    ROE

    -32.02%
    CRNX annual return on equity is -32.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CRNX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CRNX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.93
    CRNX price to book ratio is 2.93

    PB ratio Sector rank

    64.06%
    CRNX price to book ratio is higher than 64.06% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2469.41
    CRNX price to sales ratio is 2469.41

    PS ratio Sector rank

    98.64%
    CRNX price to sales ratio is higher than 98.64% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.29B
    CRNX enterprise value is $2.29 billion

    Enterprise value Sector rank

    81.67%
    CRNX enterprise value is higher than 81.67% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.46
    CRNX EV/EBITDA is -5.46

    EV/EBITDA Sector rank

    21.74%
    CRNX EV/EBITDA is higher than 21.74% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    23.04
    CRNX annual current ratio is 23.04

    Quick ratio

    23.04
    CRNX annual quick ratio is 23.04

    Leverage

    Debt to equity

    0.04
    CRNX annual debt to equity ratio is 0.04

    Interest coverage ratio

    -
    CRNX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CRNX piotroski f-score value is unknown

    Altman Z-Score

    4.63
    CRNX altman z-score is 4.63

    Analyst ratings

    Recent major analysts updates

    Aug 11, 25 JMP Securities
    Market Outperform
    Jun 27, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 Stifel
    Buy
    Feb 28, 25 Citizens Capital Markets
    Market Outperform
    Feb 4, 25 Wolfe Research
    Peer Perform
    Jan 22, 25 Jefferies
    Buy
    Jan 13, 25 HC Wainwright & Co.
    Buy
    Dec 16, 24 JMP Securities
    Market Outperform
    Nov 14, 24 Citigroup
    Buy
    Nov 13, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CRNX included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    • What is the ticker symbol for Crinetics Pharmaceuticals, Inc.?
    • Does Crinetics Pharmaceuticals, Inc. pay dividends?
    • What sector is Crinetics Pharmaceuticals, Inc. in?
    • What industry is Crinetics Pharmaceuticals, Inc. in?
    • What country is Crinetics Pharmaceuticals, Inc. based in?
    • When did Crinetics Pharmaceuticals, Inc. go public?
    • Is Crinetics Pharmaceuticals, Inc. in the S&P 500?
    • Is Crinetics Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Crinetics Pharmaceuticals, Inc. in the Dow Jones?
    • When was Crinetics Pharmaceuticals, Inc.'s last earnings report?
    • When does Crinetics Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Crinetics Pharmaceuticals, Inc.?

    The ticker symbol for Crinetics Pharmaceuticals, Inc. is NASDAQ:CRNX

    Does Crinetics Pharmaceuticals, Inc. pay dividends?

    No, Crinetics Pharmaceuticals, Inc. does not pay dividends

    What sector is Crinetics Pharmaceuticals, Inc. in?

    Crinetics Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Crinetics Pharmaceuticals, Inc. in?

    Crinetics Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Crinetics Pharmaceuticals, Inc. based in?

    Crinetics Pharmaceuticals, Inc. is headquartered in United States

    When did Crinetics Pharmaceuticals, Inc. go public?

    Crinetics Pharmaceuticals, Inc.'s initial public offering (IPO) was on July 18, 2018

    Is Crinetics Pharmaceuticals, Inc. in the S&P 500?

    No, Crinetics Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Crinetics Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Crinetics Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Crinetics Pharmaceuticals, Inc. in the Dow Jones?

    No, Crinetics Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Crinetics Pharmaceuticals, Inc.'s last earnings report?

    Crinetics Pharmaceuticals, Inc.'s most recent earnings report was on August 7, 2025

    When does Crinetics Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Crinetics Pharmaceuticals, Inc. is November 10, 2025
    On this page